Appraisal of Innovative Anticancer Agents: Do the Scores of European Society for Medical Oncology-Magnitude of Clinical Benefit Scale and American Society of Clinical Oncology Task Force Correlate With Survival Gains?
- PMID: 28165906
- DOI: 10.1200/JCO.2016.69.2731
Appraisal of Innovative Anticancer Agents: Do the Scores of European Society for Medical Oncology-Magnitude of Clinical Benefit Scale and American Society of Clinical Oncology Task Force Correlate With Survival Gains?
Erratum in
-
Errata.J Clin Oncol. 2017 May 10;35(14):1631. doi: 10.1200/JCO.2017.73.5381. J Clin Oncol. 2017. PMID: 28475850 Free PMC article. No abstract available.
Comment in
-
Reply to J.P. Jansen, A. Messori et al, and H.S.L. Jim et al.J Clin Oncol. 2017 Apr 1;35(10):1134. doi: 10.1200/JCO.2016.70.9246. Epub 2017 Feb 6. J Clin Oncol. 2017. PMID: 28165893 No abstract available.
Comment on
-
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received.J Clin Oncol. 2016 Aug 20;34(24):2925-34. doi: 10.1200/JCO.2016.68.2518. Epub 2016 May 31. J Clin Oncol. 2016. PMID: 27247218 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
